Purdue Pharma L.P., One Stamford Forum, Stamford, 06901-3431, USA.
Subst Use Misuse. 2010 Aug;45(10):1509-24. doi: 10.3109/10826081003682107.
To determine concurrent validity of self-reported misuse of prescription opioids.
Cross-sectional study in five U.S. methadone maintenance programs.
92 addicts.
Self-reported questionnaire assessing past-month misuse of 14 opioid analgesics, and color photographs of five opioid analgesics with instructions to mark those used in the past month "to get high." Concordance between self-report and photograph endorsement was assessed via Kappa statistic.
29 respondents completed both questionnaire and photograph endorsements. Kappas were 0.62 (OxyContin), 0.59 (methadone), 0.49 (Dilaudid), and 0.46 (generic extended-release oxycodone).
Good-to-fair concurrent validity of self-reported abuse was seen for OxyContin, methadone, Dilaudid, and generic extended-release oxycodone.
确定自我报告的处方阿片类药物滥用的同时效度。
在美国五个美沙酮维持治疗项目中进行的横断面研究。
92 名成瘾者。
自我报告的问卷评估过去一个月内 14 种阿片类镇痛药的滥用情况，以及五张阿片类镇痛药的彩色照片，并附有指示，要求在过去一个月内标记那些用于“获得快感”的药物。通过 Kappa 统计评估自我报告和照片认可之间的一致性。
29 名受访者完成了问卷和照片的认可。Kappa 值分别为 0.62（羟考酮）、0.59（美沙酮）、0.49（地佐辛）和 0.46（通用缓释羟考酮）。
羟考酮、美沙酮、地佐辛和通用缓释羟考酮的自我报告滥用具有良好到中等的同时效度。
